Zai Lab Limited (HKG:9688)
15.34
-0.01 (-0.07%)
Jul 9, 2026, 4:08 PM HKT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 17.4 billion as of July 9, 2026. Its market cap has decreased by -46.68% in one year.
Market Cap
17.40B
Enterprise Value
14.03B
Revenue
3.55B
Ranking
n/a
PE Ratio
n/a
Stock Price
15.34
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 17.40B, an increase of 1,180.34%. That is a compound annual growth rate of 33.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 17.40B | 13.92% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 28.89B |
| InnoCare Pharma | 28.14B |
| Keymed Biosciences | 24.73B |
| Duality Biotherapeutics | 18.81B |
| Metis TechBio | 14.67B |
| Shaanxi Micot Pharmaceutical Technology | 13.63B |
| Ascentage Pharma Group International | 12.51B |
| GenFleet Therapeutics (Shanghai) | 12.21B |